Jan. 13 at 10:44 PM
$NMRA The conference officially concludes on Thursday.
While many companies present early, institutional portfolio managers often wait until the entire conference field is evaluated before executing large-scale rebalancing.
We are already starting to see After-Action reports with Mizuho & Leerink Partners following Neumora's presentation.
Large executions often hit the market in the 3–5 days following the final sessions as funds finalize their 2026 convictions.
The stock jumped from a
$1.50 low on January 6 to a high of
$2.57 by January 9, a ~70% move in just four days.
Since that peak, the stock has traded in a tightening range between
$2.08 and
$2.33.
Forming a base just under the
$2.33 strike price of the new 1.2m share executive option grant is typically a sign of institutional accumulation, where buyers prevent the stock from dropping while absorbing all available sell orders before the next leg up.
$BIOA move just serves as proof that this is where the interest is.
